Type 2 diabetes mellitus (T2DM), which was once thought to be rare in sub-Saharan Africa (SSA), is now well established in this region. The SSA region is undergoing a rapid but variable epidemiological transition fuelled by the pace of urbanization, with disease burden profiles shifting from communicable diseases to non-communicable diseases (NCDs). Information on the epidemiology of T2DM has increased, but wide variations in study methods, diagnostic biomarkers and criteria hamper analytical comparison, and data from high-quality studies are limited. The prevalence of T2DM is still low in some rural populations but moderate or high rates are reported in many countries/regions, with evidence for an increase in some. In addition, the proportion of undiagnosed T2DM is still high. The prevalence of T2DM is highest in African people living in urban areas, and the gradient between African people living in urban areas and people in the African diaspora is rapidly fading. However, data from longitudinal studies are lacking and there is limited information on chronic complications and the genetics of T2DM. The large unmet needs for T2DM care call for greater investment of resources into health systems to manage NCDs in SSA. Proposed health-system paradigms are being developed in some countries/regions. However, national NCD programmes need to be adequately funded and coordinated to stem the tide of T2DM and its complications.
Previously considered rare, type 2 diabetes mellitus (T2DM) is now firmly established in sub-Saharan Africa (SSA).
Although prevalence is low in some rural populations, moderate or high rates are reported in many countries/regions, with evidence for an increase in prevalence in some areas.
Information on the burden of T2DM has increased, but there is a need for high-quality epidemiology studies using harmonized approaches for sampling, data collection and diagnostic methods.
The increase in T2DM in SSA is associated with modifiable risk factors, such as urbanization and obesity, and there is a high proportion of undiagnosed T2DM.
Data on the genetics of T2DM are emerging and suggests a greater degree of genetic diversity in T2DM susceptibility in African people compared with other populations.
There are large unmet needs for T2DM care and national programmes need to be adequately funded and coordinated; integrated models of chronic disease health care that leverage resources across health-care systems are being piloted in some countries/regions.
This is a preview of subscription content, access via your institution
Subscribe to Nature+
Get immediate online access to the entire Nature family of 50+ journals
Subscribe to Journal
Get full journal access for 1 year
only $8.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
NCD Risk Factor Collaboration. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 387, 1513–1530 (2016).
World Health Organization. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1736–1788 (2018).
International Diabetes Federation. IDF Diabetes Atlas, 9th edn. https://diabetesatlas.org/atlas/ninth-edition/ (2019).
Saeedi, P. et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res. Clin. Pract. 157, 107843 (2019).
Mbanya, J. C., Motala, A. A., Sobngwi, E., Assah, F. K. & Enoru, S. T. Diabetes in sub-Saharan Africa. Lancet 375, 2254–2266 (2010).
Atun, R. et al. Diabetes in sub-Saharan Africa: from clinical care to health policy. Lancet Diabetes Endocrinol. 5, 622–667 (2017).
McLarty, D. G., Pollitt, C. & Swai, A. B. Diabetes in Africa. Diabet. Med. 7, 670–684 (1990).
Manne-Goehler, J. et al. Diabetes diagnosis and care in sub-Saharan Africa: pooled analysis of individual data from 12 countries. Lancet Diabetes Endocrinol. 4, 903–912 (2016).
NCD Risk Factor Collaboration (NCD-RisC)–Africa Working Group. Trends in obesity and diabetes across Africa from 1980 to 2014: an analysis of pooled population-based studies. Int. J. Epidemiol. 46, 1421–1432 (2017).
Gouda, H. N. et al. Burden of non-communicable diseases in sub-Saharan Africa, 1990-2017: results from the Global Burden of Disease Study 2017. Lancet Glob. Health 7, e1375–e1387 (2019).
United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects 2019: Highlights (ST/ESA/SER.A/423) https://population.un.org/wpp/Publications/Files/WPP2019_Highlights.pdf (2019).
United Nations. Prevention and control of non-communicable diseases: Report of the Secretary-General https://undocs.org/en/A/66/83 (2011).
United Nations Development Program. Goal 3: Good Health and Well-Being https://sdgs.un.org/goals/goal3 (2016).
World Health Organization. Global action plan for the prevention and control of noncommunicable diseases 2013–2020 https://www.who.int/publications/i/item/9789241506236 (2013).
Peck, R. et al. Preparedness of Tanzanian health facilities for outpatient primary care of hypertension and diabetes: a cross-sectional survey. Lancet Glob. Health 2, e285–e292 (2014).
Nyaaba, G. N., Stronks, K., de-Graft Aikins, A., Kengne, A. P. & Agyemang, C. Tracing Africa’s progress towards implementing the Non-Communicable Diseases Global action plan 2013-2020: a synthesis of WHO country profile reports. BMC Public Health 17, 297 (2017).
Hall, V., Thomsen, R. W., Henriksen, O. & Lohse, N. Diabetes in sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review. BMC Public Health 11, 564 (2011).
Motala, A. A., Omar, M. A. & Pirie, F. J. Diabetes in Africa. Epidemiology of type 1 and type 2 diabetes in Africa. J. Cardiovasc. Risk 10, 77–83 (2003).
Levitt, N. S. Diabetes in Africa: epidemiology, management and healthcare challenges. Heart 94, 1376–1382 (2008).
World Health Organization. Diabetes mellitus: report of a WHO Study Group https://apps.who.int/iris/handle/10665/39592 (1985).
Alberti, K. G. & Zimmet, P. Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15, 539–553 (1998).
Kahn, R. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20, 1183–1197 (1997).
King, H. & Rewers, M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes Care 16, 157–177 (1993).
Peer, N. et al. Rising diabetes prevalence among urban-dwelling black South Africans. PLoS ONE 7, e43336 (2012).
Hird, T. R. et al. Burden of diabetes and first evidence for the utility of HbA1c for diagnosis and detection of diabetes in urban Black South Africans: The Durban Diabetes Study. PLoS ONE 11, e0161966 (2016).
Agyemang, C. et al. Obesity and type 2 diabetes in sub-Saharan Africans - is the burden in today’s Africa similar to African migrants in Europe? The RODAM study. BMC Med. 14, 166 (2016).
Price, A. J. et al. Prevalence of obesity, hypertension, and diabetes, and cascade of care in sub-Saharan Africa: a cross-sectional, population-based study in rural and urban Malawi. Lancet Diabetes Endocrinol. 6, 208–222 (2018).
World Health Organization. NCDs, STEPS Country Reports https://www.who.int/teams/noncommunicable-diseases/surveillance/data (2020).
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 37 (Suppl. 1), S81–S90 (2014).
World Health Organization. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation https://www.who.int/diabetes/publications/report-hba1c_2011.pdf (2011).
Shisana, O. et al. The South African National Health and Nutrition Examination Survey, 2012: SANHANES-1: the health and nutritional status of the nation. 72-98 (HSRC Press, 2014).
Ekoru, K. et al. H3Africa multi-centre study of the prevalence and environmental and genetic determinants of type 2 diabetes in sub-Saharan Africa: study protocol. Glob. Health Epidemiol. Genom. 1, e5 (2016).
Levitt, N. S., Katzenellenbogen, J. M., Bradshaw, D., Hoffman, M. N. & Bonnici, F. The prevalence and identification of risk factors for NIDDM in urban Africans in Cape Town, South Africa. Diabetes Care 16, 601–607 (1993).
Omar, M. A., Seedat, M. A., Motala, A. A., Dyer, R. B. & Becker, P. The prevalence of diabetes mellitus and impaired glucose tolerance in a group of urban South African blacks. S. Afr. Med. J. 83, 641–643 (1993).
Abubakari, A. R. et al. Prevalence and time trends in diabetes and physical inactivity among adult West African populations: the epidemic has arrived. Public Health 123, 602–614 (2009).
Werfalli, M., Engel, M. E., Musekiwa, A., Kengne, A. P. & Levitt, N. S. The prevalence of type 2 diabetes among older people in Africa: a systematic review. Lancet Diabetes Endocrinol. 4, 72–84 (2016).
Hird, T. R. Risk factors for cardiometabolic disease in the eThekwini Municipality (City of Durban), South Africa. Thesis, Univ. Cambridge https://doi.org/10.17863/CAM.13719 (2017).
Erasmus, R. T. et al. High prevalence of diabetes mellitus and metabolic syndrome in a South African coloured population: baseline data of a study in Bellville, Cape Town. S. Afr. Med. J. 102, 841–844 (2012).
Prakaschandra, D. R., Esterhuizen, T. M., Motala, A. A., Gathiram, P. & Naidoo, D. P. High prevalence of cardiovascular risk factors in Durban South African Indians: the Phoenix Lifestyle Project. S. Afr. Med. J. 106, 284–289 (2016).
Galbete, C. et al. Dietary patterns and type 2 diabetes among Ghanaian migrants in Europe and their compatriots in Ghana: the RODAM study. Nutr. Diabetes 8, 25 (2018).
Levitt, N. S. et al. Increased risk of dysglycaemia in South Africans with HIV; especially those on protease inhibitors. Diabetes Res. Clin. Pract. 119, 41–47 (2016).
NCD Risk Factor CollaborationFactor. Collaboration (NCD-RisC). Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331,288 participants. Lancet Diabetes Endocrinol. 3, 624–637 (2015).
Rathod, S. D. et al. Glycated haemoglobin A1c (HbA1c) for detection of diabetes mellitus and impaired fasting glucose in Malawi: a diagnostic accuracy study. BMJ Open 8, e020972 (2018).
Hird, T. R. et al. HIV infection and anaemia do not affect HbA1c for the detection of diabetes in black South Africans: evidence from the Durban Diabetes Study. Diabet. Med. 38, e14605 (2021).
American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care 44 (Suppl. 1), S15–S33 (2021).
Mayega, R. W. et al. Comparison of fasting plasma glucose and haemoglobin A1c point-of-care tests in screening for diabetes and abnormal glucose regulation in a rural low income setting. Diabetes Res. Clin. Pract. 104, 112–120 (2014).
Peer, N., George, J., Lombard, C., Levitt, N. & Kengne, A. P. Associations of glycated albumin and fructosamine with glycaemic status in urban black South Africans. Clin. Chim. Acta 519, 291–297 (2021).
Abdullah, A., Peeters, A., de Courten, M. & Stoelwinder, J. The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabetes Res. Clin. Pract. 89, 309–319 (2010).
DeFronzo, R. A. et al. Type 2 diabetes mellitus. Nat. Rev. Dis. Primers 1, 15019 (2015).
Mahajan, A. et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat. Genet. 50, 1505–1513 (2018).
Liu, Y. & Lou, X. Type 2 diabetes mellitus-related environmental factors and the gut microbiota: emerging evidence and challenges. Clinics 75, e1277 (2020).
Ahmed, S. A. H., Ansari, S. A., Mensah-Brown, E. P. K. & Emerald, B. S. The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus. Clin. Epigenet. 12, 104 (2020).
Erasmus, R. T. et al. Importance of family history in type 2 black South African diabetic patients. Postgrad. Med. J. 77, 323–325 (2001).
Mbanya, J. C., Pani, L. N., Mbanya, D. N., Sobngwi, E. & Ngogang, J. Reduced insulin secretion in offspring of African type 2 diabetic parents. Diabetes Care 23, 1761–1765 (2000).
Adeleye, J. O. & Abbiyesuku, F. M. Glucose and insulin responses in offspring of Nigerian type 2 diabetics. Afr. J. Med. Med. Sci. 31, 253–257 (2002).
Asamoah, E. A. et al. Heritability and genetics of type 2 diabetes mellitus in sub-Saharan Africa: a systematic review and meta-analysis. J. Diabetes Res. 2020, 3198671 (2020).
Danquah, I. et al. The TCF7L2 rs7903146 (T) allele is associated with type 2 diabetes in urban Ghana: a hospital-based case-control study. BMC Med. Genet. 14, 96 (2013).
Guewo-Fokeng, M. et al. Contribution of the TCF7L2 rs7903146 (C/T) gene polymorphism to the susceptibility to type 2 diabetes mellitus in Cameroon. J. Diabetes Metab. Disord. 14, 26 (2015).
Nanfa, D. et al. Association between the TCF7L2 rs12255372 (G/T) gene polymorphism and type 2 diabetes mellitus in a Cameroonian population: a pilot study. Clin. Transl Med. 4, 17 (2015).
Chen, J. et al. Genome-wide association study of type 2 diabetes in Africa. Diabetologia 62, 1204–1211 (2019).
Adeyemo, A. A. et al. ZRANB3 is an African-specific type 2 diabetes locus associated with beta-cell mass and insulin response. Nat. Commun. 10, 3195 (2019).
Scott, R. A. et al. An expanded genome-wide association study of type 2 diabetes in Europeans. Diabetes 66, 2888–2902 (2017).
Hwang, J. Y. et al. Genome-wide association meta-analysis identifies novel variants associated with fasting plasma glucose in East Asians. Diabetes 64, 291–298 (2015).
Cole, J. B. & Florez, J. C. Genetics of diabetes mellitus and diabetes complications. Nat. Rev. Nephrol. 16, 377–390 (2020).
Liu, C. et al. Genome-wide association study for proliferative diabetic retinopathy in Africans. NPJ Genom. Med. 4, 20 (2019).
Fuchsberger, C. et al. The genetic architecture of type 2 diabetes. Nature 536, 41–47 (2016).
Ekoru, K. et al. Genetic risk scores for cardiometabolic traits in sub-Saharan African populations. Int. J. Epidemiol. 50, 1283–1296 (2021).
Martin, A. R. et al. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat. Genet. 51, 584–591 (2019).
Meeks, K. A. C. et al. Epigenome-wide association study in whole blood on type 2 diabetes among sub-Saharan African individuals: findings from the RODAM study. Int. J. Epidemiol. 48, 58–70 (2019).
Grieco, G. E. et al. The landscape of microRNAs in βcell: between phenotype maintenance and protection. Int. J. Mol. Sci. 22, 803 (2021).
Ying, W. et al. Adipose tissue macrophage-derived exosomal mirnas can modulate in vivo and in vitro insulin sensitivity. Cell 171, 372–384 (2017).
Matsha, T. E. et al. MicroRNA profiling and their pathways in South African individuals with prediabetes and newly diagnosed type 2 diabetes mellitus. Oncotarget 9, 30485–30498 (2018).
Goedecke, J. H. & Olsson, T. Pathogenesis of type 2 diabetes risk in black Africans: a South African perspective. J. Intern. Med. 288, 284–294 (2020).
Goedecke, J. H. et al. Ethnic differences in hepatic and systemic insulin sensitivity and their associated determinants in obese black and white South African women. Diabetologia 58, 2647–2652 (2015).
Evans, J. et al. Depot- and ethnic-specific differences in the relationship between adipose tissue inflammation and insulin sensitivity. Clin. Endocrinol. 74, 51–59 (2011).
Crowther, N. J., Cameron, N., Trusler, J. & Gray, I. P. Association between poor glucose tolerance and rapid post natal weight gain in seven-year-old children. Diabetologia 41, 1163–1167 (1998).
Ekoru, K. et al. Type 2 diabetes complications and comorbidity in sub-Saharan Africans. EClinicalMedicine 16, 30–41 (2019).
Sobngwi, E. et al. Type 2 diabetes control and complications in specialised diabetes care centres of six sub-Saharan African countries: the Diabcare Africa study. Diabetes Res. Clin. Pract. 95, 30–36 (2012).
Mbanya, J. C. & Sobngwi, E. Diabetes in Africa. Diabetes microvascular and macrovascular disease in Africa. J. Cardiovasc. Risk 10, 97–102 (2003).
Hayfron-Benjamin, C. et al. Microvascular and macrovascular complications in type 2 diabetes Ghanaian residents in Ghana and Europe: The RODAM study. J. Diabetes Complications 33, 572–578 (2019).
Burgess, P. I. et al. High prevalence in Malawi of sight-threatening retinopathy and visual impairment caused by diabetes: identification of population-specific targets for intervention. Diabet. Med. 31, 1643–1650 (2014).
Ojo, A. Addressing the global burden of chronic kidney disease through clinical and translational research. Trans. Am. Clin. Climatol. Assoc. 125, 229–243 (2014).
Crews, D. C., Pfaff, T. & Powe, N. R. Socioeconomic factors and racial disparities in kidney disease outcomes. Semin. Nephrol. 33, 468–475 (2013).
Naicker, S. End-stage renal disease in sub-Saharan Africa. Ethn. Dis. 19 (Suppl. 1), S1-13-5 (2009).
Engidaw, N. A., Wubetu, A. D. & Basha, E. A. Prevalence of depression and its associated factors among patients with diabetes mellitus at Tirunesh-Beijing general hospital, Addis Ababa, Ethiopia. BMC Public Health 20, 266 (2020).
Mohamed, H. G. et al. Association between oral health status and type 2 diabetes mellitus among Sudanese adults: a matched case-control study. PLoS ONE 8, e82158 (2013).
Abegunde, D. O., Mathers, C. D., Adam, T., Ortegon, M. & Strong, K. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 370, 1929–1938 (2007).
GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385, 117–171 (2015).
Renzaho, A. M. The post-2015 development agenda for diabetes in sub-Saharan Africa: challenges and future directions. Glob. Health Action 8, 27600 (2015).
Hove, M., Ngwerume, E. T. & Muchemwa, C. The urban crisis in Sub-Saharan Africa: a threat to human security and sustainable development. Stab. Int. J. Security Dev. 2, 7 (2003).
Agyei-Mensah, S. & de-Graft Aikins, A. Epidemiological transition and the double burden of disease in Accra, Ghana. J. Urban. Health 87, 879–897 (2010).
Manne-Goehler, J. et al. Health system performance for people with diabetes in 28 low- and middle-income countries: A cross-sectional study of nationally representative surveys. PLoS Med. 16, e1002751 (2019).
Chan, J. C. N. et al. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. Lancet 396, 2019–2082 (2021).
International Diabetes Federation. Type 2 Diabetes Clinical Practise Guidelines for sub-Saharan Africa: IDF Africa Region https://www.worlddiabetesfoundation.org/sites/default/files/Type_2_IDF_Diabetes_Practical_Guidelines_small_eng.pdf (2006).
World Health Organization. Global Status Report on Noncommunicable Diseases 2014 https://www.who.int/publications/i/item/9789241564854 (2014).
World Health Organization. The Global Burden of Disease: 2004 update https://www.who.int/publications/i/item/9789241563710 (2004).
Lupafya, P. C., Mwagomba, B. L., Hosig, K., Maseko, L. M. & Chimbali, H. Implementation of policies and strategies for control of noncommunicable diseases in Malawi: challenges and opportunities. Health Educ. Behav. 43, 64s–69s (2016).
Remais, J. V., Zeng, G., Li, G., Tian, L. & Engelgau, M. M. Convergence of non-communicable and infectious diseases in low- and middle-income countries. Int. J. Epidemiol. 42, 221–227 (2013).
Rabkin, M. et al. Strengthening Health systems for chronic care: leveraging HIV programs to support diabetes services in Ethiopia and Swaziland. J. Trop. Med. 2012, 137460 (2012).
Njuguna, B. et al. Models of integration of HIV and noncommunicable disease care in sub-Saharan Africa: lessons learned and evidence gaps. AIDS 32 (Suppl. 1), S33–S42 (2018).
Bekele, H., Asefa, A., Getachew, B. & Belete, A. M. Barriers and strategies to lifestyle and dietary pattern interventions for prevention and management of type-2 diabetes in Africa, systematic review. J. Diabetes Res. 2020, 7948712 (2020).
K.E. is supported by the Centre for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health (NIH), USA. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official view of the NIH.
PubMed was searched using keywords including ‘diabetes and sub-Saharan Africa/Africa’, ‘diabetes prevalence and sub-Saharan Africa/Africa’, ‘risk of diabetes and sub-Saharan Africa/Africa’, ‘epidemiology of diabetes and sub-Saharan Africa/Africa’, ‘urbanization/urban/rural and diabetes and sub-Saharan Africa/Africa’, ‘physical activity and diabetes and Africa’, ‘genetics of diabetes and sub-Saharan Africa/Africa’, ‘GWAS and type 2 diabetes and sub-Saharan Africa’, ‘mortality and diabetes and Africa’, ‘HIV and diabetes and Africa’, ‘standards of care and sub-Saharan Africa’, ‘diabetes and … [each country in sub-Saharan Africa]’. Published peer-reviewed reviews and book chapters were included. The World Health Organization (WHO), International Diabetes Federation (IDF), United Nations and World Bank publications were used and their websites were also accessed for relevant information.
The authors declare no competing interests.
Peer review information
Nature Reviews Endocrinology thanks R. Erasmus, B. Longo-Mbenza and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Motala, A.A., Mbanya, J.C., Ramaiya, K. et al. Type 2 diabetes mellitus in sub-Saharan Africa: challenges and opportunities. Nat Rev Endocrinol 18, 219–229 (2022). https://doi.org/10.1038/s41574-021-00613-y